# Efficacy and Safety of Celecoxib in Chinese Patients with Ankylosing Spondylitis: A 6-Week Randomized, Double-Blinded Study with 6-Week Open-Label Extension Treatment

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-celecoxib-in-chinese-patients-with-ankylosing-spondylitis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Feng Huang,Jieruo Gu,Yi Liu,Ping Zhu,Yi Zheng,Jin Fu,Sharon Pan,Le Shi |
| Citations | 21 |
| DOI | 10.1016/j.curtheres.2014.08.002 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1016/j.curtheres.2014.08.002 |
| OpenAlex ID | https://openalex.org/W1996422252 |
| PMID | 25516774 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Sharon Pan](https://scholariq.org/researchers/sharon-pan/)

## Paper primary topic

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Paper topics

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Spine and Intervertebral Disc Pathology](https://scholariq.org/topics/spine-and-intervertebral-disc-pathology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.